Related Experiment Video
Updated: Jun 6, 2025

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Advances in Epigenetic Therapeutics for Breast Cancer
Michel-Gael F Guefack1, Sanchita Bhatnagar2
1Department of Medical Microbiology and Immunology, University of California Davis School of Medicine, Davis, CA, USA.
Epigenetic alterations drive breast cancer progression and treatment resistance. Targeting these epigenetic changes, through enzyme inhibitors or combined therapies, offers promising new strategies for breast cancer treatment.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic deregulation is a key driver in breast cancer, influencing tumor development, therapeutic resistance, and metastasis.
- Aberrant epigenomic mechanisms are prevalent in breast cancer, necessitating novel therapeutic approaches.
Purpose of the Study:
- To review the targeting of epigenetic mechanisms in breast cancer therapy.
- To highlight current epigenetic research for developing novel breast cancer treatments.
Main Methods:
- Review of current literature on epigenetic mechanisms in breast cancer.
- Analysis of selective inhibitors of epigenetic enzymes.
- Evaluation of combined epigenetic therapies with conventional treatments.
Main Results:
- Epigenetic alterations are strongly linked to breast cancer progression and treatment failure.
- Targeting epigenetic enzymes shows potential as a therapeutic strategy.
- Combination therapies involving epigenetic agents demonstrate promise.
Conclusions:
- Targeting epigenetic mechanisms represents a significant frontier in breast cancer therapeutic development.
- Epigenetic therapies, alone or in combination, offer promising avenues for improving breast cancer treatment outcomes.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

